Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1992 | 12-1991 | 12-1990 | |
| Sales | 18,890 | 26,472 | 26,472 |
| Cost of Goods | 13,490 | 18,257 | 18,257 |
| Gross Profit | 5,400 | 8,216 | 8,216 |
| Operating Expenses | 380 | 7,439 | 7,439 |
| Operating Income | 5,020 | 776 | 776 |
| Interest Expense | 300 | 402 | 402 |
| Other Income | -4,500 | 1 | 1 |
| Pre-tax Income | 220 | 374 | 374 |
| Income Tax | 10 | 32 | 32 |
| Net Income Continuous | 210 | 342 | 342 |
| Net Income | $210 | $342 | $342 |
| EBITDA(a) | $5,020 | $1,177 | $1,177 |